within Pharmacolibrary.Drugs.ATC.M;

model M03BB02
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.0007333333333333333,
    adminDuration  = 600,
    adminMass      = 0.4,
    adminCount     = 1,
    Vd             = 0.0011,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.002,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Chlormezanone is a centrally acting muscle relaxant that was used for the treatment of muscle spasms and anxiety. It is no longer widely approved or available due to rare but severe cases of hepatotoxicity.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic parameters for a typical adult based on limited published information and reviews; no detailed pharmacokinetic clinical studies identified.</p><h4>References</h4><ol><li>N Bernard, J P Fauvel, N Pozet, N Ferry, G Cuisinaud, P Haond, P Chapuy, J Sassard,Pharmacokinetics of chlormezanone in elderly patients.,European journal of clinical pharmacology,1991<a href='https://pubmed.ncbi.nlm.nih.gov/1815974/'>https://pubmed.ncbi.nlm.nih.gov/1815974/</a></li><li>C KÃ¶ppel, J Kristinsson, A Wagemann, J Tenczer, F Martens,Chlormezanone plasma and blood levels in patients after single and repeated oral doses and after suicidal drug overdose.,European journal of drug metabolism and pharmacokinetics,1991<a href='https://pubmed.ncbi.nlm.nih.gov/1936060/'>https://pubmed.ncbi.nlm.nih.gov/1936060/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end M03BB02;
